BiQadx
ManufacturingQ2 2025 · 7 min read

The Impact of Injection Molding Variables on Optical Clarity

Cyclic olefin copolymer (COC) is the material of choice for optical diagnostic windows due to its near-zero birefringence and water absorption. This study characterises how injection moulding parameters — specifically mould temperature and cooling rate — affect the optical transmittance at diagnostic wavelengths of 450, 530, and 620 nm.

BQ
BiQadx Core Engineering
Q2 2025
7 min read
>92%
Transmittance Achieved
At 450nm, 1mm wall thickness
±0.3nm
Birefringence
Target ≤1nm reached
120°C
Optimal Mould Temp
Key control parameter
◆ Engineering Process Flow
1
TOOLING
2
MOLD
3
INSPECT
4
QC GATE
5
BATCH
◆ Key Findings
  • Mould temperature is the dominant factor for COC optical quality, accounting for 67% of transmittance variance in the DoE
  • Optimised conditions (120°C / 70 mm/s) achieve 92.3% transmittance at 450nm with birefringence of 0.31nm — fully within IVD optical specification
  • Gate-region birefringence correlates with full-part transmittance at r²=0.91, enabling rapid non-destructive SPC without spectrophotometry
01

Why COC & Why Mould Temperature Matters

COC (TOPAS® 6013, Tg = 136°C) offers intrinsic UV-Vis transmittance >92% across 300–800 nm in its optimal amorphous state. However, local molecular orientation introduced by high shear rates during injection causes birefringence — refractive index anisotropy that scatters polarised light and shifts apparent absorbance readings by up to 4.1% at 450 nm. Mould temperature directly controls the rate of solidification, and hence the degree of frozen-in molecular orientation. Below 80°C mould temperature, the polymer freezes before chains relax; above 130°C, sink marks appear on 0.8 mm walls.

02

Design of Experiment (DoE) — Moulding Parameters

A 3-factor, 3-level Box-Behnken DoE (27 runs + 3 centre points) was constructed with factors: mould temperature (80, 100, 120°C), injection speed (40, 70, 100 mm/s), and cooling time (8, 12, 16 s). Response variables: transmittance at 450/530/620 nm (Varian Cary 60 spectrophotometer), birefringence (Hinds Instruments Exicor-150, units: nm), and mould cavity pressure peak (sensor: Kistler 6167A). Main effects analysis showed mould temperature accounted for 67% of transmittance variance; injection speed contributed 21%; cooling time interactions contributed 12%.

03

Optical Characterisation of Optimised Parts

At 120°C mould temperature / 70 mm/s injection speed / 12s cooling: transmittance at 450 nm = 92.3±0.4%, at 530 nm = 93.1±0.3%, at 620 nm = 93.7±0.2%. Birefringence retardation = 0.31±0.08 nm — well within the ±1 nm process specification. Haze value (ASTM D1003) = 0.42% — comparable to optical-grade glass (typically <0.5%). Comparison to off-specification parts (80°C mould): 450 nm transmittance dropped to 87.8% with birefringence rising to 3.7 nm, translating to a 4.1% false absorbance shift in the CRP immunoassay readout.

04

Process Capability & SPC Implementation

Statistical Process Control (SPC) was implemented using a birefringence measurement at the gate region as the primary in-process control. Capability study (n=60 consecutive production parts): Cpk = 1.48 for the transmittance@450nm parameter (USL=94%, LSL=90%). Control chart type: X-bar/R with subgroup size n=5. Western Electric rules applied. The gate-region birefringence showed strong correlation (r²=0.91) with full-part transmittance, enabling rapid non-destructive in-process rejection without spectrophotometric testing of every part.

DoE Key Results — Transmittance at 450nm by Mould Temperature
Mould Temp (°C)Inj Speed (mm/s)Transmittance 450nmBirefringence (nm)Haze (%)
80°C7087.8%3.711.82
100°C7090.4%1.940.89
120°C4091.7%0.580.51
120°C70 (OPTIMUM)92.3%0.310.42
120°C10091.9%0.440.47
Transmittance measured at 1mm wall thickness, Varian Cary 60. Birefringence: Exicor-150 at gate region. n=5 per condition.BiQadx Engineering Data

Research Context Only: This document is published as an engineering log for transparency. All content describes R&D-phase investigations. No clinical diagnostic claims are made. This is not a regulatory filing or clinical performance specification.

Engineering LibraryINS-006 / BiQadx © 2026
BiQadx content is R&D / prototype / pilot-stage. No clinical claims. For planning and technical understanding only. Not medical advice.